Flu and Mood in Older Adults
NCT03956329 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 654
Last updated 2021-10-06
Summary
Randomised control trial comparing the effects of a standardised and individualised positive affect digital intervention versus usual care on mood and antibody responses to influenza vaccination in older adults.
Conditions
- Vaccination
- Infection
Interventions
- OTHER
-
Standardised Digital Intervention
Video intervention designed to induce an increase in positive mood in older adults. Includes comedy clips, uplifting music and positive imagery. Intervention approximately 15-20 minutes in length. This includes 3 short comedy clips (fork handles sketch, the two Ronnie's; A room with a view - faulty towers; Tim Vine Live stand-up extract), uplifting music (Jailhouse Rock - Elvis Presley; Happy Together - The Turtles), jokes and positive imagery. The content of the intervention has been informed by patient and public involvement, focus groups with older adults, and pilot testing.
- OTHER
-
Individualised Digital Intervention
Similar to the standardised digital intervention, however, participants will be able to individualise the intervention by choosing video clips from a limited menu of choices. Intervention approximately 15-20 minutes in length. The 4 categories include stand-up comedy (Michael McIntyre, Tim Vine and Victoria Wood), sit-com (Fawlty Towers, Only Fools and Horses and Two Ronnies), music (Elvis Presley, Last Night at the Proms, Roy Orbison) and variety (Britain's Got Talent, Strictly Come Dancing, Terry Wogan). Participants are able to select 3 of the videos, which are roughly 5 minutes in length, to reach a total of 15-20 minutes of content.
Sponsors & Collaborators
-
Public Health England
collaborator OTHER_GOV -
University of Nottingham
lead OTHER
Principal Investigators
-
Kavita Vedhara · University of Nottingham
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-08-12
- Primary Completion
- 2019-11-07
- Completion
- 2020-05-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
NCT01766921 ·Status: COMPLETED ·Phase: PHASE2
-
Th1 Response to Influenza: Aging and Vaccine Efficacy
NCT00396305 ·Status: TERMINATED ·Phase: PHASE4
-
Childhood Influenza Immunisation in General Practice Invitation Trial
NCT02921633 ·Status: COMPLETED ·Phase: NA
-
Nudge and Motivational Interviewing Interventions to Improve Influenza Vaccine Uptake Among Healthcare Workers in China
NCT07157163 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years
NCT01289535 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults
NCT05333289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong
NCT02957890 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly
NCT00938392 ·Status: COMPLETED ·Phase: PHASE3
-
Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)
NCT03392207 ·Status: COMPLETED
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
NCT00329966 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
NCT00522236 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults
NCT00943358 ·Status: COMPLETED ·Phase: PHASE1
-
Influenza Vaccine Challenge Study in Healthy Subjects
NCT01226758 ·Status: COMPLETED ·Phase: PHASE1
-
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
NCT00753272 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population
NCT00306995 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine
NCT01617239 ·Status: COMPLETED ·Phase: PHASE1
-
Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Older Adults
NCT06030726 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.
NCT00316628 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants
NCT00479648 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza Vaccination Among the Elderly Individuals
NCT02362919 ·Status: COMPLETED
-
Elderly Influenza Vaccine Immunogenicity Substudy
NCT00170482 ·Status: COMPLETED
-
Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong
NCT03330132 ·Status: COMPLETED ·Phase: PHASE4
-
Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19
NCT05115370 ·Status: COMPLETED
-
Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)
NCT03853993 ·Status: COMPLETED ·Phase: PHASE3
-
Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
NCT07327398 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2